Skip to main content
ACRV
NASDAQ Life Sciences

Acrivon Files New $300M Shelf Days After Disclosing Going-Concern Doubt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.433
Mkt Cap
$62.566M
52W Low
$1.27
52W High
$3.56
52W Position info
13% above low
Off High info
60% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ACRV is trading near its 52-week low of $1.27 (13% above the low).

Summary

Acrivon filed a new $300 million shelf registration, mostly rolled forward from its 2023 shelf, giving it the paperwork to raise cash while it warns of going-concern doubt. No shares have been sold and no terms are set.


Key Events · Financing and Capital Events · ACRV

  • New $300M Universal Shelf Filed

    Registers up to $300,000,000 of common stock, preferred stock, debt securities, warrants and units for sale from time to time; no securities have been sold and no pricing is set.

  • Most Capacity Is Rolled Forward

    Of the total, $292,701,082.80 is unsold capacity carried forward from the prior S-3 (File No. 333-275854, effective December 15, 2023) under Rule 415(a)(6); only $7,298,917.20 is newly registered, with a $635.01 fee.

  • Float Cap Limits Near-Term Raises

    Non-affiliate float was about $34.6 million as of November 10, 2026, so General Instruction I.B.6 caps sales at one-third of float — roughly $11.5 million — in any 12-month period while float stays under $75 million.

  • Filed Alongside Going-Concern Warning

    The shelf arrives the same day as the Q3 2026 10-Q, which reported a $17.9 million net loss, $77.8 million in cash, and substantial doubt about continuing as a going concern.


Analysis · ACRV · Life Sciences

The timing is what matters here: this shelf lands the same day the company's 10-Q disclosed substantial doubt about its ability to continue as a going concern, with $77.8 million in cash against a $17.9 million quarterly net loss. Acrivon registered a fresh $300 million universal shelf, but only $7.3 million of that is new capacity — the other $292.7 million is unsold capacity rolled forward from its 2023 shelf, which terminates when this one goes effective. No shares have been sold and no terms are set; any actual raise requires a separate prospectus supplement. And because the non-affiliate float is only about $34.6 million, the one-third-of-float rule caps what Acrivon can actually sell in any 12-month window at roughly $11.5 million until the float recovers — so the headline number overstates near-term firepower. Expect the real dilution news in a future 424B supplement, not here.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACRV was trading at $1.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $62.6M. The 52-week trading range was $1.27 to $3.56. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACRV - Latest Insights

ACRV
Nov 16, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.45
Real-time Price: $1.45 info
Change: $0 (0%) info
Market Cap: $62.566M info
ACRV
Nov 16, 2026, 4:03 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.45
Real-time Price: $1.45 info
Change: $0 (0%) info
Market Cap: $62.566M info
ACRV
Nov 10, 2026, 4:55 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.45 info
Change: -$0.150 (-9%) info
Market Cap: $62.566M info
ACRV
Nov 06, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.45 info
Change: -$0.150 (-9%) info
Market Cap: $62.566M info
ACRV
Nov 06, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.57
Real-time Price: $1.45 info
Change: -$0.120 (-8%) info
Market Cap: $62.566M info